Well that's just dandy! Thanks for the heads-up, Jennifer. Doesn't it make sense, then, for everyone to follow the 424 application guide and limit the summary to 30 lines? Has anyone gotten one through with a full one page summary, i.e. one that exceeds 30 lines? -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Jennifer Hyne Sent: Wednesday, April 22, 2009 5:11 PM To: xxxxxx@hrinet.org Subject: Re: [RESADM-L] Challenge Grant_Question Regarding Abstract Summary For what it's worth, we had a one-page summary (approximately 36 lines) today and our proposal errored out of the system. Here's the message we got: ERROR: The Project Summary/Abstract in Other Project Information, item 6 is limited to 30 lines of text. WARNING: The Employer Identification Number on the SF424 RR Cover page must be a length of 9 characters or 12 characters. (We had an extra space after the EIN but that was just a warning.) The entire proposal errored out SOLELY due to the length of the abstract, which was very clearly under the one page limit. Jennifer E. Hyne Research Administrator The Broad Institute of MIT and Harvard 7 Cambridge Center, NE30-7031 Cambridge, MA 02142 Phone: (617) 324-6250 Fax: (617) 452-4588 E-mail: xxxxxx@broad.mit.edu Website: http://www.broad.mit.edu Joelina Peck wrote: > > Kris, > > Thanks, the guidelines state specifically that the Asbstract/Summary > are limited to one page (see below). We contacted NIH CSR, Division of > Receipt and Referral to confirm that the project summary for the > Challenge grants are limited to one page, per the guidelines. We spoke > with Hope Fato who confirmed that the instructions in the *_guidelines > will always take precedence, and should be followed specifically._* If > the guidelines state one page, then it's one page. > > A big sigh of relief! > > *Special Instructions for Other Project Information (Section 4.4 of > SF424 (R&R) Application)* > > . *Item 6. Project Summary/Abstract: *Limited to one page.* *Begin > this section by stating the broad Challenge Area and the specific > Challenge Topic that this application addresses. Use the following > format/: This application addresses broad Challenge Area (01) > Behavior, Behavioral Change, and Prevention and specific Challenge > Topic, 01-GM-104: Mechanisms of Behavior Change Research. /Continue > with the instructions in the SF424 (R&R) Application Guide. > > *Joelina Peck, CRA* > > (480) 965- 4878 Voice mail > > (480) 280-0759 Blackberry > > (480) 965-3552 Fax > > xxxxxx@asu.edu <mailto:xxxxxx@asu.edu> > > *From:* Research Administration List [mailto:xxxxxx@hrinet.org] *On > Behalf Of *Kris Wolff > *Sent:* Wednesday, April 22, 2009 12:59 PM > *To:* xxxxxx@hrinet.org > *Subject:* Re: [RESADM-L] Challenge Grant_Question Regarding Abstract > Summary > > Sorry, and to clarify - the challenge grant RFA says to include a > section at the top of the summary with the specific challenge grant > research area information and then after that "Continue with the > instructions in the SF424 (R&R) Application Guide." That last sentence > is the part that means, keep the rest of it to 30 lines. > > ------------------------------------------------------------------------ > > *From:* Research Administration List [mailto:xxxxxx@hrinet.org] *On > Behalf Of *Joelina Peck > *Sent:* Wednesday, April 22, 2009 3:41 PM > *To:* xxxxxx@hrinet.org > *Subject:* [RESADM-L] Challenge Grant_Question Regarding Abstract Summary > > Hi All, > > I just learned that that the program summary section of the challenge > grants are limited to 30 lines of text? A department staff member > emailed NIH and received a confirmation that it is limited to 30 lines > of text. I can't find any notice updates from NIH for RFA-OD-09-003 > that address this change and according to the guidelines the > limitation listed is 1 page. Has anyone else heard this information? > Have you been using the 30 lines of text or has anyone submitted with > a one page summary? If there was an update can someone please share? > > Thanks for any information you can provide! > > *Joelina Peck, CRA* > > Resource Proposal Analyst Sr. > > Research Management Office > > The Biodesign Institute at ASU > > 1001 S. McAllister Avenue > > Tempe, AZ 85287-5001 > > (480) 965- 4878 Voice mail > > (480) 280-0759 Blackberry > > (480) 965-3552 Fax > > xxxxxx@asu.edu <mailto:xxxxxx@asu.edu> > > ====================================================================== > Instructions on how to use the RESADM-L Mailing List, including > subscription information and a web-searchable archive, are available > via our web site at http://www.hrinet.org (click on "Listserv Lists") > ====================================================================== > > ====================================================================== > Instructions on how to use the RESADM-L Mailing List, including > subscription information and a web-searchable archive, are available > via our web site at http://www.hrinet.org (click on "Listserv Lists") > ====================================================================== > > ====================================================================== > Instructions on how to use the RESADM-L Mailing List, including > subscription information and a web-searchable archive, are available > via our web site at http://www.hrinet.org (click on "Listserv Lists") > ====================================================================== > ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================
